Resultado de búsqueda
Hace 2 días · When do Pradaxa patents expire, and when can generic versions of Pradaxa launch? Pradaxa is a drug marketed by Boehringer Ingelheim and is included in two NDAs. There are three patents protecting this drug and two Paragraph IV challenges.
Hace 5 días · Late in 2010, the FDA approved a new anticoagulant drug called dabigatran (brand name Pradaxa) for the prevention of stroke in patients with an irregular heart beat called atrial fibrillation (AF). This medication is the first orally-administered alternative to warfarin (brand name Coumadin) to be approved by the FDA in the more than ...
Hace 3 días · Dabigatran etexilate mesylate. is the generic ingredient in two branded drugs marketed by Alkem Labs Ltd, Apotex, Hetero Labs Ltd Iii, and Boehringer Ingelheim, and is included in five NDAs. There are three patents protecting this compound and two Paragraph IV challenges.
Hace 4 días · Anticoagulation Management and Vascular Protection. The non-vitamin K antagonist oral anticoagulants (NOACs) have the potential to change the way thromboembolic disorders are treated.
Hace 5 días · The use of new, direct anticoagulants is increasing. Data from both controlled trials and clinical practice have shown that these drugs are as efficacious and safe as warfarin for deep vein thrombosis and pulmonary embolism, and as stroke prophylaxis for patients with atrial fibrillation.
Hace 4 días · Prävention von Schlaganfall und systemischer Embolie bei Patienten mit nicht valvulärem Vorhofflimmern mit einem oder mehreren Risikofaktoren, wie z. B. vorausgegangener Schlaganfall oder transitorische ischämische Attacke (TIA) Alter >/= 75 Jahre. Herzinsuffizienz (NYHA Klasse >/= II) Diabetes mellitus.
Hace 5 días · escuela secundaria tÉcnica n° 75 "ignacio ramÍrez" turno vespertino- cct 09dst0075q -o.p 1075 Espacio creado para la Comunidad Escolar, con el fin de consultar diferentes actividades del Plantel, Turno Vespertino.
